Tag Archives: U.S.

AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle

AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm. In an earnings call with analysts Friday, AbbVie CEO Rick Gonzalez touted the drugmaker’s… Read More »

Close to half of U.S. population projected to have obesity by 2030

About half of the adult U.S. population will have obesity and about a quarter will have severe obesity by 2030, according to a new study led by Harvard T.H. Chan School of Public Health. The study also predicts that in 29 states, more than half of the population will have obesity, and all states will… Read More »

A stunning indictment of the U.S. health-care system, in one chart – The Washington Post

The report also shows a growing income gap in cost-related delays. In 2016, for instance, one-fourth of U.S. households earning less than $ 40,000 a year reported cost-related delays, vs. 13 percent for households making more than $ 100,000. In 2019, the rate of cost-related delays among poorer households shot up to 36 percent, while… Read More »

Can psychedelics treat anorexia, depression? U.S. scientists get millions to find out

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »